Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL) Meeting Abstract


Authors: Grommes, C.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I. K.; Deangelis, L.
Abstract Title: Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
Meeting Title: 41st European Society for Medical Oncology Congress (ESMO)
Journal Title: Annals of Oncology
Volume: 27
Issue: Suppl. 6
Meeting Dates: 2016 Oct 7-11
Meeting Location: Copenhagen, Denmark
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2016-10-01
Language: English
ACCESSION: WOS:000393912500330
DOI: 10.1093/annonc/mdw367.09
PROVIDER: wos
Notes: Meeting Abstract: 331PD -- Source: Wos
Altmetric Score
MSK Authors
  1. Antonio Marcilio Padula Omuro
    180 Omuro
  2. Thomas Kaley
    94 Kaley
  3. Christian Grommes
    60 Grommes
  4. Craig Nolan
    45 Nolan
  5. Julia Catherine Wolfe
    9 Wolfe